Assignee
CARTESIAN THERAPEUTICS INC
US7 patents
Top patents by PatentIndex Score
US10934337B2Mar 2, 2021
Anti-BCMA chimeric antigen receptors
CARTESIAN THERAPEUTICS INC8 citations81
US11220535B2Jan 11, 2022
Anti-BCMA chimeric antigen receptors
CARTESIAN THERAPEUTICS INC1 citations70
US12508249B2Dec 30, 2025
Methods related to administering immunosuppressants and non-allergenic antigens to reduce or prevent anaphylaxis
CARTESIAN THERAPEUTICS INC0 citations62
US12472167B2Nov 18, 2025
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both Type 1 and Type IV hypersensitivity
CARTESIAN THERAPEUTICS INC0 citations62
US12194078B2Jan 14, 2025
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
CARTESIAN THERAPEUTICS INC0 citations61
US11999773B2Jun 4, 2024
Anti-BCMA chimeric antigen receptors
CARTESIAN THERAPEUTICS INC0 citations59
US12553041B2Feb 17, 2026
Formulations and doses of pegylated uricase
CARTESIAN THERAPEUTICS INC0 citations55